# A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea

> **NCT04202068** · PHASE4 · COMPLETED · sponsor: **Xiangbei Welman Pharmaceutical Co., Ltd** · enrollment: 113 (actual)

## Conditions studied

- Gonorrhea

## Interventions

- **DRUG:** Ceftriaxone sodium and Sulbactam Sodium for injection

## Key facts

- **NCT ID:** NCT04202068
- **Lead sponsor:** Xiangbei Welman Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-03
- **Primary completion:** 2016-05-03
- **Final completion:** 2016-05-30
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202068, "A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04202068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*